<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-4809</journal-id>
<journal-title><![CDATA[Veterinaria (Montevideo)]]></journal-title>
<abbrev-journal-title><![CDATA[Veterinaria (Montev.)]]></abbrev-journal-title>
<issn>1688-4809</issn>
<publisher>
<publisher-name><![CDATA[Sociedad de Medicina Veterinaria del Uruguay]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-48092025000201401</article-id>
<article-id pub-id-type="doi">10.29155/vet.61.224.1</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Disfunción de la pars intermedia de la pituitaria: estudio de caso]]></article-title>
<article-title xml:lang="en"><![CDATA[Pituitary pars intermedia dysfunction: case study]]></article-title>
<article-title xml:lang="pt"><![CDATA[Disfunção da pars intermedia da hipófise: estudo de caso]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pardié]]></surname>
<given-names><![CDATA[Mateo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guidi]]></surname>
<given-names><![CDATA[Camila]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Frade]]></surname>
<given-names><![CDATA[Amaia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nieves]]></surname>
<given-names><![CDATA[Agustina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carzoli]]></surname>
<given-names><![CDATA[Adrián]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pessina]]></surname>
<given-names><![CDATA[Paula]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de la República Facultad de Veterinaria Unidad de Clínica y Cirugía de Equinos]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de la República Facultad de Veterinaria Laboratorio de Análisis Clínicos]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<volume>61</volume>
<numero>224</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-48092025000201401&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-48092025000201401&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-48092025000201401&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen La disfunción de la pars intermedia de la pituitaria (PPID; pituitary pars intermedia dysfunction) es un desorden endócrino que se presenta sobre todo en equinos gerontes, sin otra predisposición clara. Los principales signos clínicos son la hipertricosis, la letargia, la laminitis, la pérdida progresiva de peso y la atrofia de masa muscular. En los casos subclínicos se puede observar solamente disminución del rendimiento deportivo e infertilidad, lo que impacta económicamente en la industria. Dado que es una patología subdiagnosticada en Uruguay no existe tratamiento disponible. El objetivo de este trabajo fue reportar el primer caso con diagnóstico definitivo de PPID en un equino en el país.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Pituitary pars intermedia dysfunction (PPID) is a common endocrine disorder in geriatric horses, affecting equines between 18 and 23 years of age, without any other clear predisposition. The main clinical signs include hypertrichosis, lethargy, laminitis, weight loss and muscle wastage. Its economic impact lies mainly in subclinical cases, which may go unnoticed, causing a decrease in performance, infertility and medical care and treatment expenses aiming to solve these aspects. It is an underdiagnosed pathology in Uruguay and no treatment is available. The purpose of this work is to report the first diagnosed PPID case in this country.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo A disfunção da pars intermedia da hipófise (PPID, pituitary pars intermedia dysfunction) é um distúrbio endócrino que ocorre principalmente em equinos idosos de 18 e 23 anos, sem outra predisposição clara. Os principais sinais clínicos são a hipertricose, letargia, laminite e perda de peso e massa muscular. O seu impacto econômico reside sobretudo nos casos subclínicos que passam despercebidos, causando diminuição do desempenho, falhas reprodutivas e gastos em cuidados médicos e tratamentos, que visam resolver apenas estes aspectos. É uma patologia subdiagnosticada no Uruguai e sem tratamento disponível. O objetivo deste trabalho é reportar o primeiro caso clínico com diagnóstico definitivo de PPID em um equino no país.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Equino]]></kwd>
<kwd lng="es"><![CDATA[Cushing]]></kwd>
<kwd lng="es"><![CDATA[Hipertricosis]]></kwd>
<kwd lng="es"><![CDATA[Pituitaria]]></kwd>
<kwd lng="en"><![CDATA[Equine]]></kwd>
<kwd lng="en"><![CDATA[Cushing]]></kwd>
<kwd lng="en"><![CDATA[Hypertrichosis]]></kwd>
<kwd lng="en"><![CDATA[Pituitary]]></kwd>
<kwd lng="pt"><![CDATA[Equino]]></kwd>
<kwd lng="pt"><![CDATA[Cushing]]></kwd>
<kwd lng="pt"><![CDATA[Hipertricose]]></kwd>
<kwd lng="pt"><![CDATA[Hipófise]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aleman]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Watson]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[D. C.]]></given-names>
</name>
<name>
<surname><![CDATA[LeCouteur]]></surname>
<given-names><![CDATA[R. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Nieto]]></surname>
<given-names><![CDATA[J. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Shelton]]></surname>
<given-names><![CDATA[G. D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Myopathy in horses with pituitary pars intermedia dysfunction (Cushing&#8217;s disease)]]></article-title>
<source><![CDATA[Disorders]]></source>
<year>2006</year>
<volume>16</volume>
<page-range>737-44</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barrell]]></surname>
<given-names><![CDATA[E. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polyuria and Polydipsia in Horses]]></article-title>
<source><![CDATA[Veterinary Clinics of North America: Equine Practice]]></source>
<year>2022</year>
<volume>38</volume>
<page-range>95-108</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Beech]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Boston]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Lindborg]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction]]></article-title>
<source><![CDATA[Journal of Veterinary Internal Medicine]]></source>
<year>2011</year>
<volume>25</volume>
<page-range>1431-8</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bennaim]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Shiel]]></surname>
<given-names><![CDATA[R. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Mooney]]></surname>
<given-names><![CDATA[C. T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis of spontaneous hyperadrenocorticism in dogs. Part 1: Pathophysiology, aetiology, clinical and clinicopathological features]]></article-title>
<source><![CDATA[The Veterinary Journal]]></source>
<year>2019</year>
<volume>252</volume>
<page-range>105342</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bertin]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Fraser]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<source><![CDATA[Equine Endocrinology]]></source>
<year>2020</year>
<publisher-name><![CDATA[Severn]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cabrera Blatter]]></surname>
<given-names><![CDATA[M. F.]]></given-names>
</name>
<name>
<surname><![CDATA[del Prado]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Gallelli]]></surname>
<given-names><![CDATA[M. F.]]></given-names>
</name>
<name>
<surname><![CDATA[D&#8217;Anna]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Ivanic]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Esarte]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Miceli]]></surname>
<given-names><![CDATA[D. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[N. V.]]></given-names>
</name>
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[V. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Blindness in dogs with pituitary dependent hyperadrenocorticism: Relationship with glucose, cortisol and triglyceride concentration and with ophthalmic blood flow]]></article-title>
<source><![CDATA[Research in Veterinary Science]]></source>
<year>2012</year>
<volume>92</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>387-92</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hart]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Durham]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Frank]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[McGowan]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Schott]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[A.J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Recommendations on diagnosis and management of pituitary pars intermedia dysfunction (PPID)]]></source>
<year>2021</year>
<publisher-name><![CDATA[Equine Endocrinology Group]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heinrichs]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Baumgärtner]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Capen]]></surname>
<given-names><![CDATA[C. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses]]></article-title>
<source><![CDATA[Veterinary Pathology]]></source>
<year>1990</year>
<volume>27</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>419-25</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Henneke]]></surname>
<given-names><![CDATA[D. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Potter]]></surname>
<given-names><![CDATA[G. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Kreider]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Yeates]]></surname>
<given-names><![CDATA[B.F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relationship between condition score, physical measurements and body fat percentage in mares]]></article-title>
<source><![CDATA[Equine Veterinary Journal]]></source>
<year>1983</year>
<volume>15</volume>
<page-range>371-2</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Horn]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Bamford]]></surname>
<given-names><![CDATA[N. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Afonso]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Sutherland]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Buckerfield]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[R. H. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Secombe]]></surname>
<given-names><![CDATA[C. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[A. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Bertin]]></surname>
<given-names><![CDATA[F. R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction]]></article-title>
<source><![CDATA[Equine Veterinary Journal]]></source>
<year>2019</year>
<volume>51</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>440-5</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Horn]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Jackson]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Dryburgh]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Medina-Torres]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Bertin]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses]]></article-title>
<source><![CDATA[Journal of Veterinary Internal Medicine]]></source>
<year>2021</year>
<volume>35</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>560-70</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Palmieri]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Bertin]]></surname>
<given-names><![CDATA[F. R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Correlation of pituitary histomorphometry with dopamine and dopamine D2 receptor expression in horses with pituitary pars intermedia dysfunction]]></article-title>
<source><![CDATA[Research in Veterinary Science]]></source>
<year>2022</year>
<volume>152</volume>
<page-range>427-33</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Innerå]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Petersen]]></surname>
<given-names><![CDATA[A. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Desjardins]]></surname>
<given-names><![CDATA[D. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Steficek]]></surname>
<given-names><![CDATA[B. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Rosser]]></surname>
<given-names><![CDATA[E. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Schott]]></surname>
<given-names><![CDATA[H. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of hair follicle histology between horses with pituitary pars intermedia dysfunction and excessive hair growth and normal aged horses]]></article-title>
<source><![CDATA[Veterinary Dermatology]]></source>
<year>2013</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>212-e47</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ireland]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[McGowan]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of pituitary pars intermedia dysfunction: A systematic literature review of clinical presentation, disease prevalence and risk factors]]></article-title>
<source><![CDATA[The Veterinary Journal]]></source>
<year>2018</year>
<volume>235</volume>
<page-range>22-33</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kam]]></surname>
<given-names><![CDATA[Y. N.]]></given-names>
</name>
<name>
<surname><![CDATA[McKenzie]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Coyle]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Bertin]]></surname>
<given-names><![CDATA[F. R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Repeatability of a thyrotropin-releasing hormone stimulation test for diagnosis of pituitary pars intermedia dysfunction in mature horses]]></article-title>
<source><![CDATA[Journal of Veterinary Internal Medicine]]></source>
<year>2021</year>
<volume>35</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>2885-90</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Keen]]></surname>
<given-names><![CDATA[J. A.]]></given-names>
</name>
<name>
<surname><![CDATA[McLaren]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Chandler]]></surname>
<given-names><![CDATA[K. J.]]></given-names>
</name>
<name>
<surname><![CDATA[McGorum]]></surname>
<given-names><![CDATA[B. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biochemical indices of vascular function, glucose metabolism and oxidative stress in horses with equine Cushing&#8217;s disease]]></article-title>
<source><![CDATA[Equine Veterinary Journal]]></source>
<year>2004</year>
<volume>36</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>226-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kirkwood]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pituitary pars intermedia dysfunction (PPID) in horses]]></article-title>
<source><![CDATA[Veterinary Sciences]]></source>
<year>2022</year>
<volume>9</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>556</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[F. I.]]></given-names>
</name>
<name>
<surname><![CDATA[Spence]]></surname>
<given-names><![CDATA[R. J.]]></given-names>
</name>
<name>
<surname><![CDATA[de Laat]]></surname>
<given-names><![CDATA[M. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Harris]]></surname>
<given-names><![CDATA[P. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Sonntag]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Menzies-Gow]]></surname>
<given-names><![CDATA[N. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Durham]]></surname>
<given-names><![CDATA[A. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Bailey]]></surname>
<given-names><![CDATA[S. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Sillence]]></surname>
<given-names><![CDATA[M. N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between insulin dysregulation and adrenocorticotropic hormone in aged horses and ponies with no clinical signs of pituitary pars intermedia dysfunction]]></article-title>
<source><![CDATA[Equine Veterinary Journal]]></source>
<year>2023</year>
<volume>55</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1003-11</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McFarlane]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Equine pituitary pars intermedia dysfunction]]></article-title>
<source><![CDATA[Veterinary Clinics of North America: Equine Practice]]></source>
<year>2011</year>
<volume>27</volume>
<page-range>93-113</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McFarlane]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathophysiology and clinical features of pituitary pars intermedia dysfunction]]></article-title>
<source><![CDATA[Equine Veterinary Education]]></source>
<year>2014</year>
<volume>26</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>592-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McFarlane]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Dybdal]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Donaldson]]></surname>
<given-names><![CDATA[M. T.]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Cribb]]></surname>
<given-names><![CDATA[A. E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nitration and increased alpha-synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction]]></article-title>
<source><![CDATA[Journal of Neuroendocrinology]]></source>
<year>2005</year>
<volume>17</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>73-80</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McFarlane]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Hale]]></surname>
<given-names><![CDATA[G. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[E. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Maxwell]]></surname>
<given-names><![CDATA[L. K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fecal egg counts after anthelmintic administration to aged horses and horses with pituitary pars intermedia dysfunction]]></article-title>
<source><![CDATA[Journal of the American Veterinary Medical Association]]></source>
<year>2010</year>
<volume>236</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>330-4</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McGowan]]></surname>
<given-names><![CDATA[T. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Pinchbeck]]></surname>
<given-names><![CDATA[G. P.]]></given-names>
</name>
<name>
<surname><![CDATA[McGowan]]></surname>
<given-names><![CDATA[C. M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses]]></article-title>
<source><![CDATA[Equine Veterinary Journal]]></source>
<year>2013</year>
<volume>45</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>74-9</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meyer]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Hunyadi]]></surname>
<given-names><![CDATA[L. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ordóñez-Mena]]></surname>
<given-names><![CDATA[J. M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The accuracy of ACTH as a biomarker for pituitary pars intermedia dysfunction in horses: A systematic review and meta-analysis]]></article-title>
<source><![CDATA[Equine Veterinary Journal]]></source>
<year>2022</year>
<volume>54</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>457-66</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[A. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Loynachan]]></surname>
<given-names><![CDATA[A. T.]]></given-names>
</name>
<name>
<surname><![CDATA[Bush]]></surname>
<given-names><![CDATA[H. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Hart]]></surname>
<given-names><![CDATA[K. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Barker]]></surname>
<given-names><![CDATA[V. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Campana-Emard]]></surname>
<given-names><![CDATA[A. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Grubbs]]></surname>
<given-names><![CDATA[S. T.]]></given-names>
</name>
<name>
<surname><![CDATA[Adams]]></surname>
<given-names><![CDATA[A. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses]]></article-title>
<source><![CDATA[Domestic Animal Endocrinology]]></source>
<year>2021</year>
<volume>74</volume>
<page-range>106531</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Millington]]></surname>
<given-names><![CDATA[W. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Dybdal]]></surname>
<given-names><![CDATA[N. O.]]></given-names>
</name>
<name>
<surname><![CDATA[Dawson]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Manzini]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Mueller]]></surname>
<given-names><![CDATA[G. P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Equine Cushing&#8217;s disease: differential regulation of beta-endorphin processing in tumors of the intermediate pituitary]]></article-title>
<source><![CDATA[Endocrinology]]></source>
<year>1988</year>
<volume>123</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1598-604</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morgan]]></surname>
<given-names><![CDATA[R. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Keen]]></surname>
<given-names><![CDATA[J. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Homer]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Nixon]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[McKinnon-Garvin]]></surname>
<given-names><![CDATA[A. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Moses-Williams]]></surname>
<given-names><![CDATA[J. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[S. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Hadoke]]></surname>
<given-names><![CDATA[P. W. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[B. R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dysregulation of cortisol metabolism in equine pituitary pars intermedia dysfunction]]></article-title>
<source><![CDATA[Endocrinology]]></source>
<year>2018</year>
<volume>159</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>3791-800</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Orth]]></surname>
<given-names><![CDATA[D. N.]]></given-names>
</name>
<name>
<surname><![CDATA[Holscher]]></surname>
<given-names><![CDATA[M. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[M. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Nicholson]]></surname>
<given-names><![CDATA[W. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Plue]]></surname>
<given-names><![CDATA[R. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Mount]]></surname>
<given-names><![CDATA[C. D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Equine Cushing&#8217;s disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests]]></article-title>
<source><![CDATA[Endocrinology]]></source>
<year>1982</year>
<volume>110</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1430-41</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pease]]></surname>
<given-names><![CDATA[A. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Schott]]></surname>
<given-names><![CDATA[H. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Howey]]></surname>
<given-names><![CDATA[E. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Patterson]]></surname>
<given-names><![CDATA[J. S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Computed tomographic findings in the pituitary gland and brain of horses with pituitary pars intermedia dysfunction]]></article-title>
<source><![CDATA[Journal of Veterinary Internal Medicine]]></source>
<year>2011</year>
<volume>25</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1144-51</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rohrbach]]></surname>
<given-names><![CDATA[B. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Stafford]]></surname>
<given-names><![CDATA[J. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Clermont]]></surname>
<given-names><![CDATA[R. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Reed]]></surname>
<given-names><![CDATA[S. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Schott]]></surname>
<given-names><![CDATA[H. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Andrews]]></surname>
<given-names><![CDATA[F. M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnostic frequency, response to therapy, and long-term prognosis among horses and ponies with pituitary par intermedia dysfunction, 1993-2004]]></article-title>
<source><![CDATA[Journal of Veterinary Internal Medicine]]></source>
<year>2012</year>
<volume>26</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1027-34</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schott]]></surname>
<given-names><![CDATA[H. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pituitary pars intermedia dysfunction: equine Cushing&#8217;s disease]]></article-title>
<source><![CDATA[Veterinary Clinics of North America: Equine Practice]]></source>
<year>2002</year>
<volume>18</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>237-70</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Spelta]]></surname>
<given-names><![CDATA[C. W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management]]></article-title>
<source><![CDATA[Veterinary Medicine]]></source>
<year>2015</year>
<volume>6</volume>
<page-range>293-300</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Spelta]]></surname>
<given-names><![CDATA[C.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Axon]]></surname>
<given-names><![CDATA[J.E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Case series of equine pituitary pars intermedia dysfunction in a tropical climate]]></article-title>
<source><![CDATA[Australian Veterinary Journal]]></source>
<year>2012</year>
<volume>90</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>451-6</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tatum]]></surname>
<given-names><![CDATA[R. C.]]></given-names>
</name>
<name>
<surname><![CDATA[McGowan]]></surname>
<given-names><![CDATA[C. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ireland]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of pergolide for the management of equine pituitary pars intermedia dysfunction: A systematic review]]></article-title>
<source><![CDATA[Veterinary Journal]]></source>
<year>2020</year>
<volume>266</volume>
<page-range>105562</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
